Report Overview
Report Summary
Summary
Leukemia is a type of cancer which is formed in blood tissues. Leukemia occurs in bone marrow which is a soft tissue. Leukemia develops by the uncontrolled growth of blood cells in the bone marrow. Leukemia is also defined as a cancer of white blood cells. Leukemia therapeutics consists of three steps including induction therapy, consolidation therapy and maintenance therapy.
In recent time there is increased use of leukemia therapeutic due to rising number of cancer diseases across the world. Rising aging population, lifestyle factors and increasing awareness for healthcare are some of the key driving factors for the growth of the global leukemia therapeutics market. In addition, innovative and targeted drug delivery is also fuelling the growth of the global leukemia therapeutics market. However, availability of large numbers of generic form of drugs and limited treatment options are some of the major factors restraining the growth of the global leukemia therapeutics market. In addition, high unmet need for diagnosis is also restraining the growth of the global leukemia therapeutics market.
North America followed by Europe dominates the global leukemia therapeutics market due to rising incidence of cancer and growing aging population. Asia is expected to show high growth rate due to rising incidence of cancer. China and India are expected to be the fastest growing leukemia markets in Asia region. Some of the key driving forces for the leukemia therapeutic market in emerging countries are increasing R&D investment, large pool of patients and rising government funding.
In 2020, the global Leukemia Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% between 2021 and 2027.
This report studies the Leukemia Therapeutic market size by players, regions, product types and end industries, history data 2017-2020 and forecast data 2021-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Genzyme
Novartis International
Pfizer
Roche Holding
Celgene Corporation
Ariad Pharmaceuticals
Clavis Pharma
Sunesis Pharmaceuticals
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Induction Therapy
Consolidation Therapy
Maintenance Therapy
Market segment by Application, the market can be split into
Cancer Research Centers
Diagnostic Laboratories
Clinics
Hospitals
The study objectives of this report are:
To study and forecast the market size of Leukemia Therapeutic in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Leukemia Therapeutic are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Leukemia Therapeutic market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table Of Contents
Table Of Contents
Table of Contents
Leukemia Therapeutic Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Leukemia Therapeutic
1.1 Leukemia Therapeutic Market Overview
1.1.1 Leukemia Therapeutic Product Scope
1.1.2 Market Status and Outlook
1.2 Global Leukemia Therapeutic Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Leukemia Therapeutic Market by Type
1.3.1 Induction Therapy
1.3.2 Consolidation Therapy
1.3.3 Maintenance Therapy
1.4 Leukemia Therapeutic Market by End Users/Application
1.4.1 Cancer Research Centers
1.4.2 Diagnostic Laboratories
1.4.3 Clinics
1.4.4 Hospitals
2 Global Leukemia Therapeutic Competition Analysis by Players
2.1 Leukemia Therapeutic Market Size (Value) by Players (2019 and 2020)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Genzyme
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Leukemia Therapeutic Revenue (Value) (2017-2020)
3.1.5 Recent Developments
3.2 Novartis International
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Leukemia Therapeutic Revenue (Value) (2017-2020)
3.2.5 Recent Developments
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Leukemia Therapeutic Revenue (Value) (2017-2020)
3.3.5 Recent Developments
3.4 Roche Holding
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Leukemia Therapeutic Revenue (Value) (2017-2020)
3.4.5 Recent Developments
3.5 Celgene Corporation
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Leukemia Therapeutic Revenue (Value) (2017-2020)
3.5.5 Recent Developments
3.6 Ariad Pharmaceuticals
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Leukemia Therapeutic Revenue (Value) (2017-2020)
3.6.5 Recent Developments
3.7 Clavis Pharma
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Leukemia Therapeutic Revenue (Value) (2017-2020)
3.7.5 Recent Developments
3.8 Sunesis Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Leukemia Therapeutic Revenue (Value) (2017-2020)
3.8.5 Recent Developments
4 Global Leukemia Therapeutic Market Size by Type and Application (2017-2020)
4.1 Global Leukemia Therapeutic Market Size by Type (2017-2020)
4.2 Global Leukemia Therapeutic Market Size by Application (2017-2020)
4.3 Potential Application of Leukemia Therapeutic in Future
4.4 Top Consumer/End Users of Leukemia Therapeutic
5 North America Leukemia Therapeutic Development Status and Outlook
5.1 North America Leukemia Therapeutic Market Size (2017-2020)
5.2 North America Leukemia Therapeutic Market Size and Market Share by Players (2019 and 2020)
6 Europe Leukemia Therapeutic Development Status and Outlook
6.1 Europe Leukemia Therapeutic Market Size (2017-2020)
6.2 Europe Leukemia Therapeutic Market Size and Market Share by Players (2019 and 2020)
7 China Leukemia Therapeutic Development Status and Outlook
7.1 China Leukemia Therapeutic Market Size (2017-2020)
7.2 China Leukemia Therapeutic Market Size and Market Share by Players (2019 and 2020)
8 Rest of Asia Pacific Leukemia Therapeutic Development Status and Outlook
8.1 Rest of Asia Pacific Leukemia Therapeutic Market Size (2017-2020)
8.2 Rest of Asia Pacific Leukemia Therapeutic Market Size and Market Share by Players (2019 and 2020)
9 Central & South America Leukemia Therapeutic Development Status and Outlook
9.1 Central & South America Leukemia Therapeutic Market Size (2017-2020)
9.2 Central & South America Leukemia Therapeutic Market Size and Market Share by Players (2019 and 2020)
10 Middle East & Africa Leukemia Therapeutic Development Status and Outlook
10.1 Middle East & Africa Leukemia Therapeutic Market Size (2017-2020)
10.2 Middle East & Africa Leukemia Therapeutic Market Size and Market Share by Players (2019 and 2020)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Leukemia Therapeutic Market Size (Value) by Regions (2021-2027)
11.1.1 North America Leukemia Therapeutic Revenue and Growth Rate (2021-2027)
11.1.2 Europe Leukemia Therapeutic Revenue and Growth Rate (2021-2027)
11.1.3 China Leukemia Therapeutic Revenue and Growth Rate (2021-2027)
11.1.4 Rest of Asia Pacific Leukemia Therapeutic Revenue and Growth Rate (2021-2027)
11.1.5 Central & South America Leukemia Therapeutic Revenue and Growth Rate (2021-2027)
11.1.6 Middle East & Africa Leukemia Therapeutic Revenue and Growth Rate (2021-2027)
11.2 Global Leukemia Therapeutic Market Size (Value) by Type (2021-2027)
11.3 Global Leukemia Therapeutic Market Size by Application (2021-2027)
12 Leukemia Therapeutic Market Dynamics
12.1 Leukemia Therapeutic Market Opportunities
12.2 Leukemia Therapeutic Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Leukemia Therapeutic Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Leukemia Therapeutic Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source